| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |